Riverbridge Partners’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-21,609
Closed -$268K 154
2020
Q3
$268K Sell
21,609
-519
-2% -$6.1K ﹤0.01% 144
2020
Q2
$158K Sell
22,128
-2,527,922
-99% -$16.9M ﹤0.01% 144
2020
Q1
$13.8M Sell
2,550,050
-347,129
-12% -$3.1M 0.29% 86
2019
Q4
$26.2M Sell
2,897,179
-531,276
-15% -$4.32M 0.47% 70
2019
Q3
$24.7M Buy
3,428,455
+24,929
+0.7% +$179K 0.47% 69
2019
Q2
$27.1M Sell
3,403,526
-175,141
-5% -$2.07M 0.51% 66
2019
Q1
$45M Sell
3,578,667
-222,782
-6% -$3.53M 0.87% 43
2018
Q4
$75.8M Buy
3,801,449
+369,940
+11% +$8.56M 1.58% 19
2018
Q3
$97.5M Sell
3,431,509
-104,670
-3% -$2.5M 1.63% 18
2018
Q2
$74.4M Buy
3,536,179
+719,956
+26% +$13.6M 1.34% 27
2018
Q1
$40.1M Buy
2,816,223
+140,470
+5% +$2.01M 0.73% 54
2017
Q4
$32.9M Buy
2,675,753
+516,965
+24% +$7.29M 0.64% 56
2017
Q3
$38.4M Sell
2,158,788
-163,806
-7% -$3.38M 0.76% 51
2017
Q2
$58.9M Buy
+2,322,594
New +$55.9M 1.13% 32

Other funds holding EVH

Riverbridge Partners's EVH Position: Q4 2020 in Review

Riverbridge Partners sold out of Evolent Health (EVH) in Q4 2020, closing a stake of 21,609 shares — an estimated $268K sold.

Riverbridge Partners first reported a position in EVH in Q2 2017 and held it in 14 quarters. The position peaked at $97.5M in Q3 2018. 161 funds tracked by Wall St. Rank hold EVH as of Q4 2020.

  • Riverbridge Partners reported no remaining Evolent Health position as of Q4 2020 after selling out during the quarter.
  • Riverbridge Partners sold 21,609 Evolent Health shares in Q4 2020, an estimated $268K.
  • Riverbridge Partners first reported a position in Evolent Health in Q2 2017 and held it in 14 quarters.
  • Riverbridge Partners's Evolent Health position peaked at $97.5M in Q3 2018.
  • 161 funds tracked by Wall St. Rank held Evolent Health as of Q4 2020.

Based on Riverbridge Partners's 13F filing for Q4 2020, filed 22 Jan 2021.